N-Nitrosomethyl(2-methylbutyl)amine
Common Name: |
N-Nitrosomethyl(2-methylbutyl)amine |
IUPAC Name: |
2-methyl-N-(nitrosomethyl)butan-1-amine |
Molecular Formula: |
C8H14O |
SMILES: |
CCC(C)CNCN=O |
Inchi: |
1S/C6H14N2O/c1-3-6(2)4-7-5-8-9/h6-7H,3-5H2,1-2H3 |
Inchi Key: |
HPDWXKAIDOKHOC-UHFFFAOYSA-N |
Cas No: |
121432-33-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
126.20 |
Mass (g/mol) |
130.111 |
Molar Refractivity |
40.30 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
5 |
Rings |
|
TPSA |
17.07 |
Hetero Atoms |
3 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
73 |
Boiling Point (°C@760.00mm Hg) |
363.00 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.62 |
LogP |
1.346 |
iLOGP |
2.10 |
XLOGP3 |
1.90 |
WLOGP |
2.32 |
MLOGP |
1.97 |
ESOL Log S |
-1.49 |
ESOL Solubility (mg/ml) |
4.09 |
ESOL Solubility (mol/l) |
0.032 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.88 |
Ali Solubility (mg/ml) |
1.66 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.88 |
Silicos-IT Solubility (mg/ml) |
1.65 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.72 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.562 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
1 |
Acute Oral Toxicity |
2.021 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |